TELEHEALTH
1300 881 698
TELEHEALTH | 1300 881 698
New PBAC application supports immunotherapy treatment for oesophageal and gastro-oesophageal junction cancers
Tamara Grigg
Pancare is supporting Bristol Meyers Squibb in their application to the Pharmaceutical Benefits Advisory Committee (PBAC) for the funding of Nivolumab, an immunotherapy for the treatment of
Implantable drug-eluting device: pancreatic cancer research update
Linda Kerr
This multidisciplinary research collaboration has brought together leaders in Cancer Biology and Therapeutics, Oncology, and Biomedical Material Science in a project that has developed a novel drug